Familial segmental spinal myoclonus: a rare clinical feature of Friedreich’s ataxia by Rajendra Singh Jain et al.
Jain et al. SpringerPlus  (2015) 4:330 
DOI 10.1186/s40064-015-1121-5
CASE STUDY
Familial segmental spinal myoclonus: a 
rare clinical feature of Friedreich’s ataxia
Rajendra Singh Jain1, Sunil Kumar1*  and Shankar Tejwani2
Abstract 
Introduction: Friedreich’s ataxia (FRDA) is the most common autosomal recessive inherited ataxia. It is characterized 
by onset before the age of 25 year, progressive limb and truncal ataxia, lower limb areflexia, extensor plantars, dysar-
thria and impaired posterior column sensations. Other important associated features are skeletal deformity, hyper-
trophic cardiomyopathy and diabetes mellitus. Most of the patients (98%) have an unstable homozygous trinucleo-
tide (GAA) expansion in intron-1 of chromosome 9 and 2% patients are compound heterozygous for GAA expansion 
and point mutations.
Case description: We observed an adolescence onset FRDA exhibiting spinal segmental myoclonus (SSM) in a fam-
ily. Triplet repeat primed polymerase chain reaction (TP-PCR) demonstrated unstable expansion of >66 GAA repeats.
Conclusions: SSM is a unique and rare manifestation of FRDA. This might be the first case report of SSM in FRDA 
patient.
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Background
Friedreich’s ataxia (FRDA) is the most common autoso-
mal recessive inherited ataxia, with onset before 25 year 
of age. It is characterized by progressive limb and trun-
cal ataxia, lower limb areflexia, extensor plantars, dysar-
thria and loss of joint position and vibration sensations. 
Other important associated features are skeletal deform-
ity, hypertrophic cardiomyopathy and diabetes mel-
litus. FRDA is due to mutation of frataxin gene on the 
long arm of chromosome 9 (Saccà et  al. 2012; Campu-
zano et al. 1996). Majority of the patients (98%) have an 
unstable homozygous expansion of GAA trinucleotide 
whereas, 2% patients are compound heterozygous for 
GAA expansion and point mutations. GAA repeat expan-
sion length is directly related to the disease severity and 
inversely related to the age of disease onset (Filla et  al. 
1996). Point mutation in frataxin gene has been associ-
ated with various atypical clinical features (Cossée et al. 
1999; McCormack et al. 2000; Zhu et al. 2002). We have 
observed spinal segmental myoclonus (SSM) with unsta-
ble expansion of GAA repeats in frataxin gene.
Case description
A 19-year-old boy born out of non-consanguineous 
marriage with normal birth and developmental history, 
presented with insidious onset, gradually progressive 
neurologic illness for 9  years. He developed progressive 
unsteadiness of gait resulting in swaying on either side 
while walking. His parents also noticed progressive slur-
ring of speech and scoliosis of thoracic spine. He devel-
oped involuntary, brief jerky movements of his upper 
limbs for last 2 years. The severity of illness had increased 
to such an extent that the patient became bed-bound for 
6 months. There was no history of fever, headache, vom-
iting, tremor, visual impairment, hearing loss, abnormal 
behavior, cognitive decline, seizures, altered sensorium, 
bladder symptoms, diabetes mellitus, alcohol or drug 
abuse.
On physical examination, thoracic scoliosis (convex-
ity toward the left side) and pes cavus deformities were 
present. Conjunctival telangiectasia and slit-lamp exami-
nation for Kayser–Fleischer rings were negative. Higher 
cognitive functions and cranial nerves examination 
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including bilateral fundi were normal except gaze evoked 
nystagmus in both the eyes. Motor system examina-
tion revealed hypotonia, distal amyotrophy and weak-
ness (Medical Research Council Grade 4/5) in all the 
four limbs. Interestingly, frequent abnormal, brief, jerky 
movements were observed in both upper limbs (Addi-
tional file  1: Video). These involuntary jerky movement 
of arms appeared spontaneously without pain or abnor-
mal behavior. It involved the supraspinatus, deltoid, 
biceps and brachioradialis muscles. It used to worsen by 
fatigue and mental stress, but not by change in posture 
or position. The jerks were not observed during sleep. 
Generalized areflexia and positive bilateral Babinski sign 
were present. Pain, touch and temperature sensations 
were intact but vibration and joint position senses were 
impaired below the knees. Romberg’s sign was positive. 
Pancerebellar features were present including dysarthria 
with scanning character, gaze evoked nystagmus with fast 
component toward the side of gaze, finger–nose–finger 
and heel-to-shin incoordination, dysdiadochokinesia, 
truncal and limb ataxia.
Routine hemogram and serum biochemistry including 
vitamin B12 level and thyroid function tests were normal. 
Peripheral blood smear for acanthocytes was negative. 
Electrocardiography (ECG) and 2D-Echocardiography 
were normal. The compound motor action potentials 
(CMAPs) showed decreased amplitude in bilateral 
median, ulnar, peroneal and tibial nerves. The sensory 
nerve action potentials (SNAPs) were non-recordable 
in bilateral sural and superficial peroneal nerves. Con-
ventional electroencephalogram (EEG) and 24-h video-
EEG did not show any epileptic activity during abnormal 
movement of limbs. Somatosensory evoked potentials 
(SSEP) was normal. Surface electromyography (EMG) 
recordings of supraspinatus, deltoid, biceps and bra-
chioradialis muscles showed semi-rhythmic, myoclonic 
bursts with a rate of 3–4  Hz without activity in other 
muscles. The duration of EMG bursts was variable rang-
ing 100–350  ms in these muscles. From surface EMG, 
the myoclonus seems to originate in the C5–C6 spinal 
cord segments. We also performed EEG–EMG recording 
and EEG back-averaging technique to rule out any cor-
tical association. Magnetic resonance imaging (MRI) of 
spine and brain showed scoliosis of dorso-lumbar region 
with convexity towards the left side and vermian atrophy, 
respectively (Figure  1). Genetic study of nucleated cells 
in peripheral blood by “triplet repeat primed PCR (poly-
merase chain reaction) Assay” of frataxin gene revealed 
expansion of >66 GAA repeats in the intron 1.
The patient had four siblings including two sisters and 
two brothers. One of his 12  years old younger brother 
had similar complaints of progressive scoliosis, invol-
untary, brief, jerky movement of arms, unsteadiness of 
gait and swaying toward either side during walking for 
3  years. Genetic counseling was done and prognosis of 
disease was explained to the family members. He was 
started on high dose coenzyme-Q and supportive treat-
ment along with physiotherapy and occupational therapy. 
Clonazepam (0.5  mg twice a day) was given for spinal 
segmental myoclonus. There was no response to treat-
ment. He is under regular follow up for the last 2 years 
with worsening of symptoms.
Discussion and evaluation
Myoclonus is a movement disorder, presenting with sud-
den, brief, shock-like, involuntary activity of a muscle or 
group of muscles. It may be either positive results from 
brief burst of muscle activity or negative due to brief 
Figure 1 Magnetic resonance imaging (MRI) of brain showing cerebellar atrophy.
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cessation of ongoing muscle contraction. Based on pre-
sumed source of generator, myoclonus can be classified 
as spinal, subcortical or cortical (Shibasaki and Hallett 
2005). This physiological classification is the most practi-
cal in our clinical practice, since the localization of source 
guides toward the effective treatment (Caviness and 
Brown 2004). Babinski first described spinal myoclonus 
in 1913 (Babinski 1913). It is limited to few contiguous 
myotomes and may occur irregularly or semi-rhythmic, 
with the frequency ranges from 1–2 per minute to 100–
200 per minute. They are resistant to supraspinal influ-
ences like voluntary actions or sleep.
Since spinal cord has propriospinal pathways and 
segmental organization, spinal myoclonus is further 
subdivided into propriospinal or segmental myoclonus 
(Brown et al. 1994). In propriospinal myoclonus, spinal 
cord generators recruit axial muscles via long proprio-
spinal pathways (Nishiyama et al. 1994). It involves the 
flexion of axial muscles (neck, trunk and hips). Bursts 
activity on EMG are usually long-lasting for several 
hundred milliseconds whereas, spinal segmental myo-
clonus (SSM) has semi-rhythmic, involuntary contrac-
tions of muscle or a group of muscles supplied by a 
limited contiguous spinal cord segments. They are usu-
ally stimulus insensitive and exaggerated by fatigue and 
emotional stress. This rare type of myoclonus is usu-
ally rhythmic and slow (<4 Hz). There are no associated 
EEG changes.
The diagnosis of spinal myoclonus should include a 
detailed history and examination with emphasis on the 
age at onset, exacerbating or relieving factors, progres-
sion, family history and associated other neurological 
symptoms such as ataxia, visual symptoms, epilepsy and 
cognitive decline. Clinical electrodiagnostic tests (surface 
electromyography, electroencephalography, combined 
EEG–EMG study, somatosensory evoked potentials) are 
important for physiological classification of myoclonus 
(spinal, subcortical or cortical myoclonus). Surface elec-
tromyography recording is useful to determine dura-
tion, distribution and stimulus sensitivity of myoclonus. 
Though, clonazepam and levetiracetam have been tried 
in spinal myoclonus with variable success, (Keswani et al. 
2002) pharmacotherapy is usually unsatisfactory.
Our patient fulfilled the clinical criteria for FRDA: ado-
lescent onset, progressive severe limb and truncal ataxia, 
dysarthria, nystagmus, generalized areflexia, extensor 
plantar response, axonal large fiber peripheral neuropa-
thy, distal amyotrophy, scoliosis, pes cavus and positive 
family history (Harding 1981). Ancillary studies, neuro-
physiology and MRI brain also supported the diagnosis 
(Geoffroy et al. 1976). Finally, genetic analysis confirmed 
the diagnosis of FRDA. Other differential diagnosis like 
ataxia telangiectasia, spinocerebellar ataxias, hereditary 
motor and sensory polyneuropathy or alcohol abuse were 
ruled out by appropriate clinical evaluation and labora-
tory investigations.
The genetic study of GAA expansion and point muta-
tion for frataxin gene has broadened the clinical spec-
trum of FRDA. Phenotypic variability are more common 
in point mutations rather than homozygous expansion of 
triplet repeats. In our patient, genetic analysis was done 
by using “triplet repeat primed PCR (TP-PCR)” method, 
which showed unstable expansion of >66 GAA repeats in 
the intron 1. TP-PCR based genetic analysis detects only 
GAA repeats i.e. either homozygous or heterozygous will 
be positive by TP-PCR method. It is important to rule 
out point mutations, as most of the phenotypic variabil-
ity in FRDA has been observed among patients harboring 
point mutations (Potdar and Raghu 2013; Chattopadhyay 
et al. 2004). Our patient had financial constraint. There-
fore, we could perform TP-PCR based genetic analysis 
only, which confirmed the diagnosis of FRDA. There are 
very few case reports described in the literature regard-
ing association of abnormal involuntary movements 
and Friedreich ataxia. Hanna et  al. (1998) reported two 
patients of FRDA exhibiting generalized chorea who 
were homozygous for frataxin gene. Zhu et  al. (2002) 
described atypical presentation (chorea and myoclonus) 
of FRDA due to deletion of frataxin gene. Along with the 
classic presentation, our patient had a unique and rare 
clinical feature of SSM.
During myoclonic jerks, our patient was conscious, 
oriented and following commands and his conventional 
EEG, video EEG and SSEP were normal, which ruled out 
the possibility of cortical and subcortical myoclonus. 
Surface EMG showed semi-rhythmic, myoclonic bursts 
of 3–4  Hz in C5–C6 innervated myotomes (supraspi-
natus, deltoid, biceps and brachioradialis). EEG–EMG 
recording and EEG back-averaging technique were also 
performed to rule out any cortical association. Similar 
myoclonus in his younger sibling and development of spi-
nal myoclonus after a long time from the disease onset, 
clearly ruled out any coincidental occurrence.
Though, the primary abnormality is in the spinal cord, 
SSM is usually associated with multiple etiologic fac-
tors such as infection, myelitis, spinal cord tumors, spi-
nal cord trauma, syringomyelia, cervical spondylosis and 
vascular malformations. The etiopathogenesis of spinal 
segmental myoclonus remains unknown. Various pos-
tulated mechanisms are re-excitation of local aberrant 
axons, abnormal hyperactivity of segmental anterior 
horn cells, local inhibitory loss of dorsal horn interneu-
rons and inhibitory loss from suprasegmental descending 
pathways (Jankovic and Pardo 1986). We speculate that 
the possible mechanism of spinal segmental myoclonus 
in our patient could be related to spinal cord damage 
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due to long-standing disease or may be due to abnormal 
nucleotide expansion in frataxin gene.
Conclusions
SSM is a unique and rare manifestation of FRDA. This 
might be the first case report of SSM in FRDA patient.
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Additional file
Additional file 1: Video. Video clip showing sudden, involuntary, brief, 
jerky movement in both the arms appearing spontaneously without pain 
or abnormal behavior. It involved the supraspinatus, deltoid, biceps and 
brachioradialis muscles, but not the other limb muscles. It worsened by 
mental stress, but not by the posture or position. During episodes patient 
was conscious and well oriented.
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